A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yimin,Li

第一单位： Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis, Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.

作者： Yimin,Li ^[1] ; Yuhui,Li ^[1] ; Yuguang,Wang ^[2] ; Lianjie,Shi ^[3] ; Fuan,Lin ^[4] ; Zongxue,Zhang ^[2] ; Jingli,Zhang ^[5] ; Yanying,Liu ^[1] ; Xu,Liu ^[1] ; Fangjingwei,Xu ^[6] ; Xiaolin,Sun ^[1]

作者单位： Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis, Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China. ^[1] Department of Respiratory, Beijing Hospital of Traditional Chinese Medicine, Beijing, China. ^[2] Department of Rheumatology, Peking University International Hospital, Beijing, China. ^[3] Department of Rheumatology, People's Hospital of Jianyang City, Jianyang, China. ^[4] Department of Rheumatology, Hongqi Hospital of Mudanjiang Medical University, Mudanjiang, China. ^[5] R&D Management Department, China National Biotec Group, Beijing, China. ^[6]

关键词 anti-MDA5 antibody dermatomyositis rapidly progressive interstitial lung disease risk marker risk prediction

DOI 10.3389/fmed.2021.733599

PMID 34646845

发布时间 2021-10-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in medicine

2021年8卷

733599页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis.

Frontiers in medicine

相似文献

Frontiers in medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis.

Frontiers in medicine

相似文献

Frontiers in medicine

相关期刊

检索历史清除